SCHEMBL10512779

SCHEMBL10512779

C=Cc1cccc2c(Nc3ccc(O)cc3C)c(C(=O)CCC)cnc12.CCCC(=O)c1cnc2c(C=O)cccc2c1Nc1ccc(O)cc1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9271993 0.96 — —
SCHEMBL9268862 0.95 — —
SCHEMBL10514598 0.93 — —
SCHEMBL10513774 0.90 — —
SCHEMBL9272700 0.85 ATP4A (0.71) —
SCHEMBL9508768 0.82 — —
SCHEMBL9513133 0.82 — —
SCHEMBL9506370 0.82 — —
SCHEMBL9267855 0.81 — —
Hydrochloric Acid SCHEMBL9265163 0.81 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0330485-A1 4-Amino-3-acyl quinoline derivatives and their use as inhibitors of gastric acid secretion SmithKline Beecham Intercredit B.V. (NL) 1989-08-30 — — EP disclosed
Send feedback